GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.24M | 1.64M | 1.03M | 1.60M | 1.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.65M | 2.00M | 2.66M | 3.37M | 2.90M |
| Operating Income | -1.65M | -2.00M | -2.66M | -3.37M | -2.90M |
| Income Before Tax | -1.64M | -2.00M | -2.66M | -3.36M | -2.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.64M | -2.00M | -2.66M | -3.36M | -2.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.64M | -2.00M | -2.66M | -3.36M | -2.89M |
| EBIT | -1.65M | -2.00M | -2.66M | -3.37M | -2.90M |
| EBITDA | -1.65M | -2.00M | -2.66M | -3.36M | -2.90M |
| EPS Basic | -0.91 | -1.61 | -13.25 | -35.88 | -36.72 |
| Normalized Basic EPS | -0.57 | -1.01 | -8.28 | -22.42 | -22.95 |
| EPS Diluted | -0.91 | -1.61 | -13.25 | -35.88 | -36.72 |
| Normalized Diluted EPS | -0.57 | -1.01 | -8.28 | -22.42 | -22.95 |
| Average Basic Shares Outstanding | 1.81M | 1.24M | 200.70K | 93.60K | 78.80K |
| Average Diluted Shares Outstanding | 1.81M | 1.24M | 200.70K | 93.60K | 78.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |